Elkfork Partners’s AbbVie ABBV Stock Holding History

Elkfork Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$8.43M	Buy	111,276 +40,876	+58%	+$2.8M	0.21%	95
2019 Q2	$5.12M	Sell	70,400 -2,816	-4%	-$221K	0.13%	154
2019 Q1	$5.9M	Sell	73,216 -60,148	-45%	-$4.92M	0.15%	141
2018 Q4	$12.3M	Sell	133,364 -48,488	-27%	-$4.26M	0.35%	64
2018 Q3	$17.2M	Buy	181,852 +35,552	+24%	+$3.37M	0.41%	63
2018 Q2	$13.6M	Buy	146,300 +10,362	+8%	+$1.01M	0.35%	68
2018 Q1	$12.9M	Buy	135,938 +68,068	+100%	+$7.48M	0.35%	63
2017 Q4	$6.56M	Buy	67,870 +51,590	+317%	+$4.86M	0.18%	117
2017 Q3	$1.45M	Sell	16,280 -2,486	-13%	-$189K	0.04%	281
2017 Q2	$1.36M	Sell	18,766 -330	-2%	-$22.2K	0.04%	286
2017 Q1	$1.24M	Sell	19,096 -4,598	-19%	-$289K	0.04%	291
2016 Q4	$1.48M	Buy	+23,694	New	+$1.45M	0.05%	256

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Elkfork Partners's ABBV Position: Q3 2019 in Review

Elkfork Partners increased its AbbVie (ABBV) stake by 58% in Q3 2019, buying an estimated $2.8M and bringing the position to 111,276 shares worth $8.43M. The position accounts for 0.21% of the portfolio, ranked #95.

Elkfork Partners first reported a position in ABBV in Q4 2016 and has held it in 12 quarters since. The position peaked at $17.2M in Q3 2018. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

Elkfork Partners held 111,276 shares of AbbVie worth $8.43M as of Q3 2019.
Elkfork Partners bought 40,876 AbbVie shares in Q3 2019, an estimated $2.8M.
AbbVie made up 0.21% of Elkfork Partners's portfolio in Q3 2019, its #95 holding.
Elkfork Partners first reported a position in AbbVie in Q4 2016 and has held it in 12 quarters since.
Elkfork Partners's AbbVie position peaked at $17.2M in Q3 2018.
2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.